Overview
- Description
Developer of a novel combination treatment effective against all multidrug-resistant pathogens deemed as a critical priority by the WHO.
- Website
- Country
- France
- Sector
- Health Biotechnology
A novel combination treatment effective against all multidrug-resistant pathogens deemed as a critical priority by the WHO
Developer of a novel combination treatment effective against all multidrug-resistant pathogens deemed as a critical priority by the WHO.